Charles K Gayer - Net Worth and Insider Trading
Charles K Gayer Net Worth
The estimated net worth of Charles K Gayer is at least $2 Million dollars as of 2024-06-20. Charles K Gayer is the Chief Commercial Officer of BioCryst Pharmaceuticals Inc and owns about 307,533 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $2 Million. Details can be seen in Charles K Gayer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles K Gayer has not made any transactions after 2024-05-13 and currently still holds the listed stock(s).
Transaction Summary of Charles K Gayer
Charles K Gayer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles K Gayer owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Charles K Gayer’s form 4 insider trades.
Insider Ownership Summary of Charles K Gayer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-05-13 | Vice President and CCO |
Charles K Gayer Latest Holdings Summary
Charles K Gayer currently owns a total of 1 stock. Charles K Gayer owns 307,533 shares of BioCryst Pharmaceuticals Inc (BCRX) as of May 13, 2024, with a value of $2 Million.
Latest Holdings of Charles K Gayer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-05-13 | 307,533 | 6.00 | 1,845,198 |
Holding Weightings of Charles K Gayer
Charles K Gayer Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles K Gayer has made a total of 2 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 30,000 shares on May 13, 2024, which cost Charles K Gayer around $164,100.
Insider Trading History of Charles K Gayer
- 1
Charles K Gayer Trading Performance
GuruFocus tracks the stock performance after each of Charles K Gayer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles K Gayer is %. GuruFocus also compares Charles K Gayer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles K Gayer within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles K Gayer's insider trading performs compared to the benchmark.
Performance of Charles K Gayer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.66 |  | | | | |
| Relative Return to S&P 500(%) | 6.59 | | | | | |
Charles K Gayer Ownership Network
Charles K Gayer Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Charles K Gayer is the Vice President and CCO of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , VP & General Counsel & Corp Sec Alane P Barnes , and director & CEO Jon P Stonehouse .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Charles K Gayer made 1 insider transaction in BioCryst Pharmaceuticals Inc (BCRX) with a net purchase of 30,000. Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 70,000 shares made by Jon P Stonehouse , a net purchase of 23,000 shares made by Helen M. Thackray , and a net sale of 8,689 shares made by Machelle Sanders .
In summary, during the past 3 months, insiders sold 11,387 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 183,601 shares, with a net purchase of 172,214 shares. During the past 18 months, 135,253 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 48,348 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Charles K Gayer Mailing Address
Above is the net worth, insider trading, and ownership report for Charles K Gayer. You might contact Charles K Gayer via mailing address: 4505 Emperor Blvd., Suite 200, Durham Nc 27703.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
